General Facts and Figures Classification Presentation History Physical Exam Labs Radiology Diagnosis Criteria for diagnosis Differential Microbiology General Specific organisms Pharmacology Drug Classes Mechanism of action Resistance Treatment General Site of care Medication Duration Assessment of responce Prevention References Literature cited Complete bibliography Links More...		Treatment Assessment of Response parameters to monitor include respiratory symptoms, temperature, PO2, and WBC resolution of symptoms may occur slowly, especially in patients with coexisting illness; fever should resolve within 2-4 days and leukocytosis within 4-5 days 26 repeat films are not indicated unless the clinical condition worsens or fails to improve failure to improve can result from the presence of: a resistant organism, a nonbacterial pathogen, an unusual pathogen, a noninfectious cause, an infectious complication, or the presence of immunosuppression 27 if the patient fails to improve, reevaluate the case considering the above possibilities; repeat labs (blood cultures, urine cultures; check sputum for Legionella, TB, mycobacteria, or fungi), get an ECG to rule-out MI 28 Footnotes: 25) Campbell GD, Overview of community-acquired pneumonia: prognosis and clinical features, Medical Clinics of North America 1994, 78:1035-1048. 26) Bartlett JG, Mundy LM, Community-acquired pneumonia, NEJM 1995 Dec 14, 333(24):1618-24. 27) Campbell GD, Overview of community-acquired pneumonia: prognosis and clinical features, Medical Clinics of North America 1994, 78:1035-1048. 28) Campbell GD, Overview of community-acquired pneumonia: prognosis and clinical features, Medical Clinics of North America 1994, 78:1035-1048.

medschool.ucsd.edu/curricular_resources/MED/CAP/index.html   3/30/99